NASDAQ: VCYT
Veracyte Inc Stock Ownership - Who owns Veracyte?

Insider buying vs selling

Have Veracyte Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Annie McGuireSVP General Counsel2025-12-16100$43.68
$4.37kSell
Annie McGuireSVP General Counsel2025-12-1610,639$43.13
$458.84kSell
Karin EasthamDirector2025-12-0510,000$7.60
$76.00kBuy
Karin EasthamDirector2025-12-056,392$44.52
$284.57kSell
Karin EasthamDirector2025-12-0510,000$7.94
$79.40kBuy
Karin EasthamDirector2025-12-0512,808$45.84
$587.08kSell
Karin EasthamDirector2025-12-05800$46.59
$37.27kSell
Annie McGuireSVP General Counsel2025-12-04720$47.10
$33.91kSell
Rebecca ChambersChief Financial Officer2025-12-048,537$46.61
$397.94kSell
Rebecca ChambersChief Financial Officer2025-12-044,741$47.25
$224.01kSell

1 of 9

VCYT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VCYT insiders and whales buy or sell their stock.

VCYT Shareholders

What type of owners hold Veracyte Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc16.51%13,052,114$497.02MInstitution
Vanguard Group Inc10.76%8,504,088$323.84MInstitution
Artisan Partners Limited Partnership9.32%7,370,467$280.67MInstitution
Fmr LLC8.60%6,795,697$258.78MInstitution
Ark Investment Management LLC5.65%4,465,775$170.06MInstitution
State Street Corp5.31%4,199,674$159.92MInstitution
Samuel D. Colella4.57%3,616,221$137.71MInsider
Brian G. Atwood4.57%3,616,221$137.71MInsider
Versant Ventures III LLC4.57%3,616,221$137.71MInsider
Tpg Group Holdings Sbs Advisors Inc4.49%3,551,929$135.26MInsider

1 of 3

VCYT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VCYT67.83%32.17%Net SellingNet Selling
CPRX84.02%15.89%Net SellingNet Selling
ERAS71.42%28.58%Net BuyingNet Buying
EWTX87.72%12.28%Net BuyingNet Buying
IRON57.85%42.15%Net SellingNet Selling

Veracyte Stock Ownership FAQ

Who owns Veracyte?

Veracyte (NASDAQ: VCYT) is owned by 113.49% institutional shareholders, 53.84% Veracyte insiders, and 0.00% retail investors. Samuel D. Colella is the largest individual Veracyte shareholder, owning 3.62M shares representing 4.57% of the company. Samuel D. Colella's Veracyte shares are currently valued at $137.71M.

If you're new to stock investing, here's how to buy Veracyte stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.